Key terms

About AGIO

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest AGIO news

Apr 08 10:50pm ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Gilead Sciences (GILD) and Agios Pharma (AGIO) by TipRanks Mar 14 12:50pm ET Cantor Fitzgerald biotech analysts hold an analyst/industry conference call by TipRanks Mar 14 11:41am ET Cantor Fitzgerald biotech analysts hold an analyst/industry conference call by TipRanks Feb 26 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 26 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 18 11:46pm ET Optimistic Outlook for Agios Pharma: A Buy Rating Amidst Pyrukynd Sales Miss and Promising ENERGIZE-T Trial Prospects by TipRanks Feb 16 5:08am ET Buy Rating for Agios Pharma Amid Expanding Drug Pipeline and Strong Commercial Prospects by TipRanks Feb 15 4:05pm ET Buy Rating Justified by Agios Pharma’s Promising Trials and Future Prospects by TipRanks Feb 15 7:03am ET Agios Pharmaceuticals reports 2023 EPS ($6.33), consensus ($6.26) by TipRanks Feb 08 7:21am ET Agios Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald by TipRanks Jan 23 7:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Gilead Sciences (GILD) and Agios Pharma (AGIO) by TipRanks Jan 23 7:00am ET Agios Pharmaceuticals price target raised to $31 from $30 at JPMorgan by TipRanks

No recent press releases are available for AGIO

AGIO Financials

1-year income & revenue

Key terms

AGIO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AGIO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching